Skip to main content

Soligenix, Inc.

SNGX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0000812796

No open-market purchases or sales by Soligenix, Inc. insiders were filed in the last 90 days; 17 institutions reported holding it in 13F filings for Q2 2026, worth $369.6K in total; no superinvestor holds it.

Holders of 5% or more of SNGX

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Soligenix, Inc., largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of SNGX
HolderLatest formStakeChangeFirst filedLatest filingFiling
MJL Manager LLC13G5.70%983.6K sharesNewJun 25, 20261 filingJun 25, 2026SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

4 Schedule 13D and 13G filings on Soligenix, Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on SNGX
Filed (ET)FilerFormStakeChangeEvent dateFiling
Jun 25, 20263:27 PM ETMJL Manager LLCand 2 others13G5.70%983.6K sharesNewJun 22, 2026SEC
Feb 17, 20269:37 PM ETArmistice Capital, LLCand 1 other13G/A4.99%529.7K shares−1.73 ppfrom 6.72%Below 5%Dec 31, 2025SEC
Nov 14, 20256:17 PM ETArmistice Capital, LLCand 1 other13G6.72%708.0K sharesNewSep 30, 2025SEC
Oct 1, 20254:48 PM ETIntracoastal Capital, LLCand 2 others13G4.99%446.4K sharesNewBelow 5%Sep 25, 2025SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Soligenix, Inc. shares.

No Form 144 notices for Soligenix, Inc. are on file.